Analystreport

Evolent Health Inc (NYSE: EVH) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.

Evolent Health, Inc Class A  (EVH) 
Last evolent health, inc class a earnings: 2/25 04:02 pm Check Earnings Report
US:NYSE Investor Relations: ir.evolenthealth.com